Tres Vision Group is a leading medical and surgical eye practice, focusing on the diagnosis and treatment of vision disorders. Their services cover a wide range of eye care, including cataracts, glaucoma, diabetic retinopathy, corneal conditions, macular degeneration, and dry eyes. Founded in 1985, the company operates in the Health Care industry and is headquartered in the United States.
The company's mission is centered around providing exceptional patient care, aiming to heal and, where possible, cure or fix their patient's eyes. They emphasize a patient-centric practice philosophy and incorporate the latest state-of-the-art advances in eye care, striving to give each patient the highest quality of care. The Tres Vision Group's approach involves a collaborative care model, where a team of medical experts work together to enhance patients' outcomes and experiences.
While specific details about their last investment and investors are not available currently, Tres Vision Group's commitment to advancing eye care and its patient-centered approach make it an intriguing prospect for potential venture capital interest.
There is no investment information
No recent news or press coverage available for Tres Vision Group.